The Senate health committee today approved President Donald Trump’s nominees to lead the Centers for Disease Control and Prevention (CDC) and the Administration for Strategic Preparedness and Response (ASPR).
The approval of Erica Schwartz, MD, MPH, JD, to lead the CDC by all Republican members and one Democrat on the Senate Committee on Health, Education, Labor & Pensions means her nomination now heads to the full Senate floor.
The approval comes despite a rocky confirmation hearing, in which several senators on the committee appeared dismayed by some of Schwartz’s responses to their questions. But support from committee chair Bill Cassidy (R-LA), a key vote, assured that Schwartz would move forward.
Cassidy receives assurances, again
The nomination of Sean Kaufman, MPH, to lead ASPR also moved forward, with the nominee opposed by all Democrats on the committee. Cassidy, who assailed Kaufman for his previous criticism of vaccines during his July 15 confirmation hearing, said Kaufman had “owned up” to anti-vaccine statements.
Cassidy added that his support was contingent upon assurances he received from Department of Health and Human Services (HHS) officials.
“I am assured, if he is confirmed, [that] he will not be involved in vaccine policy, nor will he be the ultimate decision-maker on certain issues, like mRNA, because of his past statements,” Cassidy said before his vote.
Cassidy, who was defeated in a primary in May and will leave the Senate next year, has been widely criticized for his crucial vote to confirm HHS Secretary Robert F. Kennedy Jr., despite reservations about his views on vaccines. Prior to that vote, Cassidy received assurances from the Trump administration that Kennedy would not undermine US vaccine policy.
Schwartz and Kaufman are both likely to be confirmed by the full Senate.